Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies, Lancet, vol.360, pp.1903-1913, 2002. ,
Global burden of hypertension: analysis of worldwide data, Lancet, vol.365, pp.217-223, 2005. ,
Immunology in hypertension, preeclampsia, and target-organ damage, Hypertension, vol.54, pp.439-443, 2009. ,
Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition, Hypertension, vol.18, pp.132-141, 1991. ,
Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension, Am J Physiol, vol.293, pp.251-256, 2007. ,
Inflammation, angiotensin II, and hypertension, Hypertension, vol.52, 2008. ,
Macrophages regulate salt-dependent volume and blood pressure by a vascular endothelial growth factor-C-dependent buffering mechanism, Nat Med, vol.15, pp.545-552, 2009. ,
Lysozyme M-positive monocytes mediate angiotensin II-induced arterial hypertension and vascular dysfunction, Circulation, vol.124, pp.1370-1381, 2011. ,
A role for angiotensin II type 1 receptors on bone marrow-derived cells in the pathogenesis of angiotensin II-dependent hypertension, Hypertension, vol.55, pp.99-108, 2010. ,
Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure, Hypertension, vol.54, pp.537-543, 2009. ,
A novel potent vasoconstrictor peptide produced by vascular endothelial cells, Nature, vol.332, pp.411-415, 1988. ,
Interleukin-1beta, but not interleukin-6, enhances renal and systemic endothelin production in vivo, Am J Physiol, vol.295, pp.446-453, 2008. ,
Inflammatory cytokines in vascular dysfunction and vascular disease, Biochem Pharmacol, vol.78, pp.539-552, 2009. ,
Cloning and expression of a cDNA encoding an endothelin receptor, Nature, vol.348, pp.730-732, 1990. ,
Cloning of a cDNA encoding a non-isopeptide selective subtype of the endothelin receptor, Nature, vol.348, pp.732-735, 1990. ,
Human endothelin receptors characterized using reverse transcriptasepolymerase chain reaction, in situ hybridization, and subtype-selective ligands BQ123 and BQ3020: evidence for expression of ETB receptors in human vascular smooth muscle, J Cardiovasc Pharmacol, vol.22, pp.22-25, 1993. ,
Endothelin-A receptor antagonist-mediated vasodilatation is attenuated by inhibition of nitric oxide synthesis and by endothelin-B receptor blockade, Circulation, vol.97, pp.752-756, 1998. ,
Abnormal endothelin B receptor vasomotor responses in patients with Hirschprung's disease, QJM, vol.95, pp.159-163, 2002. ,
Role of endothelin-1 in hypertension, Hypertension, vol.34, pp.876-881, 1999. ,
Role for endothelin-1 in angiotensin II-mediated hypertension, Hypertension, vol.30, pp.29-34, 1997. ,
Angiotensin II increases tissue endothelin and induces vascular hypertrophy. Reversal by ET Areceptor antagonist, Circulation, vol.96, pp.1593-1597, 1997. ,
The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension, N Engl J Med, vol.338, pp.784-790, 1998. ,
Darusentan: an effective endothelin A receptor antagonist for treatment of hypertension, Am J Hypertens, vol.15, pp.583-589, 2002. ,
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial, Lancet, vol.374, pp.1423-1431, 2009. ,
ETA activation mediates angiotensin II-induced infiltration of renal cortical T cells, J Am Soc Nephrol, vol.22, pp.2187-2192, 2011. ,
Endothelin A receptor blockade decreases expression of growth factors and collagen and improves matrix metalloproteinase-2 activity in kidneys from stroke-prone spontaneously hypertensive rats, J Cardiovasc Pharmacol, vol.39, pp.892-900, 2002. ,
Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism, J Am Soc Nephrol, vol.18, pp.143-154, 2007. ,
Reduced tissue macrophage population in the lung by anticancer agent cyclophosphamide: restoration by local granulocyte macrophage-colony-stimulating factor gene transfer, Blood, vol.99, pp.1246-1252, 2002. ,
T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury, Hypertension, vol.57, pp.469-476, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-01333877
A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension, Circ Res, vol.110, pp.1604-1617, 2012. ,
Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction, J Exp Med, vol.204, pp.2449-2460, 2007. ,
Reduced macrophage-dependent inflammation improves endothelin-1-induced vascular injury, Hypertension, vol.62, pp.112-117, 2013. ,
Studying the mononuclear phagocyte system in the molecular age, Nat Rev Immunol, vol.11, pp.788-798, 2011. ,
Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair, J Clin Invest, vol.115, pp.56-65, 2005. ,
Macrophage/monocyte depletion by clodronate, but not diphtheria toxin, improves renal ischemia/reperfusion injury in mice, Kidney Int, vol.82, pp.928-933, 2012. ,
Conditional gene targeting in macrophages and granulocytes using LysMcre mice, Transgen Res, vol.8, pp.265-277, 1999. ,
TLR2 and TLR4 agonists induce production of the vasoactive peptide endothelin-1 by human dendritic cells, Mol Immunol, vol.46, pp.3178-3182, 2009. ,
Endothelin-1 does not change the function of monocyte-derived dendritic cells grown from patients with systemic sclerosis, Immunol Invest, vol.37, pp.841-848, 2008. ,
,
Human polymorphonuclear leukocytes generate and degrade endothelin-1 by two distinct neutral proteases, J Cardiovasc Pharmacol, vol.17, pp.34-38, 1991. ,
NADPH oxidase inhibition attenuates oxidative stress but not hypertension produced by chronic ET-1, Hypertension, vol.45, pp.283-287, 2005. ,
Endothelin-1 increases glomerular permeability and inflammation independent of blood pressure in the rat, Hypertension, vol.56, pp.942-949, 2010. ,
Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt, Hypertension, vol.48, pp.286-293, 2006. ,
Endothelin-1 stimulates the biosynthesis of tumour necrosis factor in macrophages: ET-receptors, signal transduction and inhibition by dexamethasone, J Physiol Pharmacol, vol.48, pp.675-688, 1997. ,
The effect of endothelin-1 on nuclear factor kappa B in macrophages, Biochem Biophys Res Commun, vol.286, pp.968-972, 2001. ,
Endothelins, peptides with potent vasoactive properties, are produced by human macrophages, J Exp Med, vol.172, pp.1741-1748, 1990. ,
Tumor endothelin-1 enhances metastatic colonization of the lung in mouse xenograft models of bladder cancer, J Clin Invest, vol.121, pp.132-147, 2011. ,
The endothelin-integrin axis is involved in macrophage-induced breast cancer cell chemotactic interactions with endothelial cells, J Biol Chem, vol.289, pp.10029-10044, 2014. ,
Endothelin induces rapid, dynaminmediated budding of endothelial caveolae rich in ET-B, J Biol Chem, vol.287, pp.17353-17362, 2012. ,
Pain inhibition by blocking leukocytic and neuronal opioid peptidases in peripheral inflamed tissue, FASEB J, vol.26, pp.5161-5171, 2012. ,
Mechanism of action of mycophenolate mofetil, Ther Drug Monitor, vol.17, pp.681-684, 1995. ,
A randomized controlled trial of peripheral blood mononuclear cell depletion in experimental human lung inflammation, Am J Resp Crit Care Med, vol.188, pp.449-455, 2013. ,
Role of endothelin-1 in clinical hypertension: 20 years on, Hypertension, vol.52, pp.452-459, 2008. ,
The endothelin system and its antagonism in chronic kidney disease, J Am Soc Nephrol, vol.17, pp.943-955, 2006. ,
Chronic selective endothelin a receptor antagonism reduces serum uric Acid in hypertensive chronic kidney disease, Hypertension, vol.58, pp.11-12, 2011. ,
Selective endothelin-A receptor antagonism reduces proteinuria, blood pressure, and arterial stiffness in chronic proteinuric kidney disease, Hypertension, vol.57, pp.772-779, 2011. ,
, , 2018.
Guidelines for the management of arterial hypertension, Eur Heart J, vol.39, pp.3021-3104, 2018. ,
,